NICE Actimize and Finastra Announce Partnership to Provide Xceed Cloud-Native Platform to Finastra’s Customers
With “Always On” AI-based technology, NICE Actimize’s Xceed platform simplifies cloud deployments and optimizes operational…
With “Always On” AI-based technology, NICE Actimize’s Xceed platform simplifies cloud deployments and optimizes operational…
IRVINE, Calif.–(BUSINESS WIRE)–CoreLogic (NYSE: CLGX), a leading global provider of property information, insight, analytics and…
Retail, banking and financial technology experts join the Signifyd team to provide guidance and seamless…
MIAMI, FL / ACCESSWIRE / March 4, 2021 / Grand Capital Ventures, Inc.‘s (OTC PINK:GRCVD)…
HALIFAX, NS / ACCESSWIRE / March 4, 2021 / Metamaterial Inc. (“Company” or “META”) (CSE:MMAT)…
TORONTO, ON and NEW YORK, NY / ACCESSWIRE / March 4, 2021 / GlobeX Data…
The financing round is led by existing investors Alan Howard and Christian Angermayer with his…
4 March 2021 – London, UK – Crossword Cybersecurity Plc (AIM:CCS, “Crossword”, the “Company” or…
Thursday 4 March 2021 – Proving its expertise as a Managed SMS Procurement Services provider,…
London, UK, Thursday 4th March 2021: CMS Distribution, a leading value-added distributor of business and…
Streamlined Collaboration Breaks Security Silos, Empowers Rapid Dissemination of Strategic Threat Intelligence Among Internal Analysts…
Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003 – Authorization…
Scaling up R&D, manufacturing and commercial capabilities in Shanghai and Hangzhou Investing in state-of-the-art facilities…
Press Release Nicox’s NCX 470 Receives Approval by Chinese Authorities for Local Start of Denali…
8.3% patients on placebo and 6.7% patients on filgotinib had a 50% or more…
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma Submission supported by data…
– Biologics License Application (BLA) for IV efgartigimod accepted for review by U.S. Food and…
Geneva, Switzerland, March 4, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical…
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO)…